top of page

THE OG

Investor Session

April 10 @ 4 PM EST
Exclusive Cannabis Industry Insights + Live Q&A
April 10 @ 4 PM EST | Exclusive Cannabis Industry Insights + Live Q&A

The OG Investor Session

Cannabis Industry Insights + Live Q&A

A photo of an Organigram team member in protectholding a tray of young cannabis plants, the foliage of another tray of plants are blurred in the foreground

GROW WITH US

Setting the standard for excellence across the industry.

Our future is green

With a proven track record of innovation, operational excellence, and market leadership, Organigram is positioned for sustainable growth in the rapidly evolving global cannabis industry. ​ We are committed to creating value-driven opportunities, delivering trusted products, and advocating for a responsible, transparent industry.

A photo of an Organigram team member at our Mocton site wearing a white labcoat, hair net and beard net, the worker is washing out a large metal drum with a hose

Investor Resources

Access the latest investor materials, including presentations, annual reports, and financial disclosures. Stay informed on key updates, company performance, and strategic developments.

Apr 02, 2025

Organigram Global to Host the OG Investor Session, its Inaugural Virtual Event for Investors, and Announcement of Name Change on TSX and NASDAQ

Apr 01, 2025

Organigram Enters U.S. Through Acquisition of Collective Project Beverages

Mar 26, 2025

Organigram Unveils Bold New Brand Identity Reflecting Market Leadership Position in Canada and Growing International Presence

Press Releases

2025 Q1

Financial Statement
Management Discussion & Analysis
Press Release
Earnings Call Recording
Earnings Call Transcript

2024 Q4

Financial Statement
Management Discussion & Analysis
Press Release

2024 Q3

Financial Statement
Management Discussion & Analysis
Press Release

2024 Q2

Financial Statement
Management Discussion & Analysis
Press Release

QUARTERLY REPORTS

2025 Q1

Financial Statement
Management Discussion & Analysis
Press Release
Earnings Call Recording
Earnings Call Transcript

2024 Q4

Financial Statement
Management Discussion & Analysis
Press Release
Earnings Call Recording
Earnings Call Transcript

2024 Q3

Financial Statement
Management Discussion & Analysis
Press Release
Earnings Call Recording
Earnings Call Transcript

2024 Q2

Financial Statement
Management Discussion & Analysis
Press Release
Earnings Call Recording
Earnings Call Transcript

COMPETITIVE ADVANTAGE

With advanced cultivation, cutting-edge product innovation, strong brands, proprietary technology, and a growing global presence, Organigram delivers premium quality, differentiation, and sustained market leadership

A photo of our Edison JOLTS ready for inspecting, several groupings of 10 lozenges can be seen sitting on a tray

Explore the science, and consumer-centric innovations that sets us apart.

A close up photo of a number of Boxhot vape cartridges filled with oil, all upright in trays for inspection, the first row of carts is in focus and the following rows blur into the backgroud

A pioneer in Canada, learn more about our broad portfolio of leading recreational brands.

A photo of an employee at our Moncton facility, weighing large quantities of cannabis in clear bags which will be shipped internationally

With customers, partners, and collaborations all over the world, explore our global footprint.

FAQ

  • Shares of Organigram Holdings Inc. are traded on the TSX and on the NASDAQ Global Select Exchange under the ticker symbol OGI.

  • Shares of Organigram Holdings Inc. cannot be purchased directly from the Company. You can contact a broker dealer for assistance re: purchasing shares.

  • If you are a registered stockholder and have questions regarding your holdings or if there are account changes to be made to the account (mailing address, account name, shareholder documentation requests), please contact Organigram’s transfer agent:


    TSX Trust Company
    Toll Free: 1 866 600-5869
    Email:  tmxeinvestorservices@tmx.com

    If you own shares through a brokerage account, contact the broker who is responsible for your account.

  • Our current share data can be found at TMX.

  • Organigram’s head office is located at 145 King Street West, Toronto, Ontario, M5H 1J8. We also have an office and indoor facility located at 35 English Drive Moncton, New Brunswick E1E 3X3.

  • Organigram’s fiscal year ends September 30. Our quarters are Q1 (December 31), Q2 (March 31), and Q3 (June 30).

  • They can also be found under Financials. These documents are also available under our corporate profile at Sedar+ and EDGAR.

  • Insider share ownership information is available on the System for Electronic Disclosure by Insiders (“SEDI”).

  • Organigram does not distribute analyst reports on the Company. If you would like to access analyst research, please contact the brokerage houses themselves. For brokerage houses, please see our Analyst Coverage chart.

  • You can contact us at investors@organigram.ca.

bottom of page